Please assess the completion status of the following clinical trial:

Trial Title: Intracutaneous Sterile Water Injections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* multiparous women~* spontaneous labor~* at least 18 years of age~* presenting for vaginal delivery with cervical dilation of 4 centimeters or less~Exclusion Criteria:~* nulliparous~* less than 18 years old~* contraindication to placement of neuraxial anesthetic~* skin infection in area to be injected~* medical therapies considered to result in tolerance to opioids~* history of chronic pain (requiring regular medical follow-up with pain specialists)~* recent use of opioid analgesics (within the year preceding pregnancy)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Sterile Water Injection (Type: ACTIVE_COMPARATOR): In the sitting position, study subjects will receive a total of 0.4 mL of study drug via four intracutaneous injections: bilateral injections at the posterior superior iliac spine and bilateral injections at 1 cm medial and 1-2 cm inferior to the first point.
- Normal Saline Injection (Type: PLACEBO_COMPARATOR): In the sitting position, study subjects will receive a total of 0.4 mL of study drug via four intracutaneous injections: bilateral injections at the posterior superior iliac spine and bilateral injections at 1 cm medial and 1-2 cm inferior to the first point.

Based on this trial design, predict the completion outcome and termination type (if applicable).